|
Aptus Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
109.76 Cr.
|
P/BV
|
12.44
|
Book Value (Rs.)
|
12.87
|
|
52 Week High/Low (Rs.)
|
169/81
|
FV/ML
|
10/2000
|
P/E(X)
|
35.41
|
|
Bookclosure
|
|
EPS (Rs.)
|
4.52
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 6.37 | 5.32 | 1.30 |
| Diluted EPS (Rs.) | 6.37 | 5.32 | 1.30 |
| Cash EPS (Rs.) | 6.73 | 33.76 | 12.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 13.93 | 58.88 | 32.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 13.93 | 58.88 | 32.28 |
| Revenue From Operations / Share (Rs.) | 49.12 | 595.23 | 463.25 |
| PBDIT / Share (Rs.) | 9.85 | 52.40 | 20.64 |
| PBIT / Share (Rs.) | 9.32 | 45.25 | 14.61 |
| PBT / Share (Rs.) | 8.39 | 37.27 | 9.84 |
| Net Profit / Share (Rs.) | 6.20 | 26.61 | 6.48 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 20.06 | 8.80 | 4.45 |
| PBIT Margin (%) | 18.98 | 7.60 | 3.15 |
| PBT Margin (%) | 17.08 | 6.26 | 2.12 |
| Net Profit Margin (%) | 12.62 | 4.46 | 1.39 |
| Return on Networth / Equity (%) | 44.49 | 45.18 | 20.06 |
| Return on Capital Employeed (%) | 47.38 | 23.04 | 14.20 |
| Return On Assets (%) | 14.14 | 7.96 | 3.12 |
| Long Term Debt / Equity (X) | 0.37 | 2.24 | 2.07 |
| Total Debt / Equity (X) | 1.49 | 3.00 | 2.28 |
| Asset Turnover Ratio (%) | 1.54 | 2.20 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 1.63 | 2.01 | 1.81 |
| Quick Ratio (X) | 1.05 | 1.18 | 1.07 |
| Inventory Turnover Ratio (X) | 4.68 | 6.24 | 0.00 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 10.57 | 6.57 | 4.32 |
| Interest Coverage Ratio (Post Tax) (%) | 7.65 | 4.33 | 2.36 |
